Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 28(3): 323-5, Mar. 1995. ilus
Article Dans Anglais | LILACS | ID: lil-154697

Résumé

The effect of orogastric administration of Saccharomyces boulardii on the anatomopathological aspect of the jejunal villi was studied in male Fischer rats (weighing about 40 g) orogastrically infected with a culture of Vibrio cholerae. Experimental and control groups received lyophilized S. boulardii (25 mg suspended in 0.5 ml saline) or 0.5 ml saline, respectively, three times a day for 10 days by gastric intubation. On day 5 of treatment, 0.5 ml of a culture of V. cholerae containing 10(8) viable cells was inoculated by gastric intubation into both groups. Histopathological examination of the jejunal mucosa showed extensive lesions of the superficial epithelium of the villi from the control group whereas few lesions of this superficial epithelium were observed in the experimental group. These data show that the inhibition of the action of the cholera toxin on enterocytes by S. boulardii suggested by recent results in vitro can be demonstrated in vivo


Sujets)
Animaux , Rats , Toxine cholérique/antagonistes et inhibiteurs , Muqueuse intestinale/anatomopathologie , Jéjunum/anatomopathologie , Saccharomyces/physiologie , Vibrio cholerae/pathogénicité , Lignées consanguines de rats
2.
Article Dans Anglais | IMSEAR | ID: sea-22681

Résumé

The effect of Octreotide (SMS 201-995), synthetic somatostatin analogue on small intestinal and colonic fluid secretion induced respectively by cholera toxin (CT) and deoxycholic acid (DCA) was investigated in rabbits using in vivo isolated loops. After exposure to CT and DCA, marked fluid accumulation was observed in the small intestinal and colonic loops, along with elevation of jejunal and colonic mucosal cyclic AMP concentrations. Octreotide inhibited CT and DCA induced small intestinal and colonic secretion, dose-dependently. This anti-secretory effect was observed after both intramuscular and oral administration of octreotide. In contrast, octreotide did not affect the elevated mucosal cyclic AMP concentrations. These results suggest that octreotide inhibits CT and DCA induced intestinal secretion, and this anti-secretory effect is produced by affecting processes beyond cyclic AMP formation.


Sujets)
Animaux , Acides et sels biliaires/antagonistes et inhibiteurs , Toxine cholérique/antagonistes et inhibiteurs , Muqueuse intestinale/effets des médicaments et des substances chimiques , Mâle , Octréotide/pharmacologie , Lapins , Débit sécrétoire/effets des médicaments et des substances chimiques
SÉLECTION CITATIONS
Détails de la recherche